Myriad Genetics
APRIL 15, 2024
4 In a recent presentation, Dale Muzzey, PhD, Chief Scientific Officer at Myriad, summarized the findings this way: “We followed up with providers regarding their patients who screened positive for 22q. 5 Clear Benefits for Healthcare Providers and Patients The benefits to a high PPV are, well, myriad. 2022;227(1):124-125.
The Clinical Problem Solvers
MARCH 14, 2025
Her mission — preparing the next generation of diverse physician leaders in pediatric healthcare and mental health and creating partnerships between communities and academic centers — will be critical for eliminating disparities among minority populations. The Changing Characteristics of African-American Adolescent Suicides, 2001–2017.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
APRIL 24, 2025
Her mission — preparing the next generation of diverse physician leaders in pediatric healthcare and mental health and creating partnerships between communities and academic centers — will be critical for eliminating disparities among minority populations. The Changing Characteristics of African-American Adolescent Suicides, 2001–2017.
The Clinical Problem Solvers
MAY 30, 2022
As healthcare providers, we must listen to our patients and use the power of our presence to see birthing people’s full humanity and empowerment. This policy reflects a societal belief that humans are not valuable unless they provide a service. Healthcare. Published online 2021. 2020;8(1):100367. doi: 10.1016/j.hjdsi.2019.100367
GeriPal
MARCH 24, 2023
We also have Joe Shega, who is a hospice physician, and he is a Chief Medical Officer and Vice President at VITAS Healthcare. This was an investigative report about fraud and healthcare, pure fraud, pure victimization of vulnerable people. She happened to focus on some specific for-profit hospice providers. I’m excited.
GeriPal
NOVEMBER 2, 2023
I talked about lack of prestige and respect, and I talked about how healthcare system leaders and medical school deans don’t always seem to value the field of geriatrics. But then I realized who I wasn’t hearing from, I did not hear from the CEO of my organization, my healthcare organization. One was very surprising.
FDA Law
FEBRUARY 11, 2024
The three letters together provide the range of actions DEA may take: no rescheduling from schedule I (former drug officials), rescheduling to schedule III (Democratic state attorneys general), or descheduling altogether (Democratic senators). Letter 1 is signed by former DEA administrators and Directors of National Drug Policy.
Expert insights. Personalized for you.
52 
Let's personalize your content